CMIC Group’s specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology. Our resources, with an established network of Key Opinion Leaders (KOLs) in hematologic malignancies and solid tumors, will benefit your oncology project from development to marketing.

Our Edge in Oncology

Highly specialized oncology expertise

• Our team has average 10+ years of oncology experience and strong relationships with KOLs in Japan and Asia, allowing them to be on top of oncology trends. Our specialists have experiences of various study designs both of selected population and broad range of population.
• Experience with gene therapy, immune therapy or biologic treatment studies and geographic experience, covering a wide range: from rare cancers to population-based cancers.

Joint research on blood cancer with National Cancer Center Japan

• In 2020, CMIC and the National Cancer Center Japan (NCC) signed joint research agreement regarding the use of data on cancer-related gene mutations in hematologic malignancies. Click Here for more details.

Experience of Different Cancers

End-to-end Solution of CMIC Oncolgy

Consulting Services

• Strategic development planning and consultation
• Regulatory authority consultation leadership and support
• Formulation of strategic development plans
• Optimized study design
• Consulting Services 
• Japan Market Entry / IPM (Innovative Pharma Model)

Clinical Trial Services

• Project Management
• Clinical Operation
• Data Management
• Pharmacovigilance 
• Quality Assurance 
• Statistical Analysis
• Medical Writing 

Site and Patient Support

• Patient recruitment and retention
• Clinical Research Coordinator (CRC) services 
• Clinical site administration support 
• Healthcare website (HelC+) with oncology clinical trial information

Contract Sales Organization Services

• Sales and Marketing 
• Medical Affairs